Back to Regulatory Science at CDER
Within a science-based regulatory agency, such as the Center for Drug Evaluation and Research (CDER) at the FDA, the focus of science and research programs is to obtain knowledge that enhances the efficiency and consistency of the regulatory decision-making process. CDER scientists also strive to remain at the cutting-edge in order to respond quickly to unforeseen public health emergencies when new tools and techniques are required. Science and research programs support CDER’s mission to ensure the availability of drug products with proven efficacy, safety and consistent quality, and to monitor product safety during real-world use.
Click on the infographic below to view the underlying process – from identification of a new question to synthesis of knowledge and update of regulatory recommendations – that drives the wide variety of CDER science and research programs.